Patent · US Active

Composition for reducing cell senescence comprising Rho-kinase inhibitor and use thereof

US9943525B2 · kind B2 · utility

0Cited by
5References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2015
Grant dateApr 17, 2018
Priority date—
Expiry dateAug 1, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition for reducing cell senescence including a Rho-kinase inhibitor and method of treating a cell senescence-related symptom in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.